1. Had a neurological condition other than that associated with their pain diagnosis which, in the opinion of the investigator, would interfere with their ability to participate in the study 
2. Were taking a lidocaine-containing product that could not be discontinued while receiving lidocaine 
3. Were taking class 1 anti-arrhythmic drugs (e.g., mexiletine, tocainide)       
    

NCT00904202_exc_T1
Condition
neurological condition
NCT00904202_exc_T2
Condition
pain diagnosis
NCT00904202_exc_T3
Negation
other than
NCT00904202_exc_T4
Qualifier
associated with their pain diagnosis
NCT00904202_exc_T6
Drug
lidocaine-containing product
NCT00904202_exc_T7
Qualifier
could not be discontinued
NCT00904202_exc_T8
Temporal
while receiving lidocaine
NCT00904202_exc_T9
Drug
lidocaine
NCT00904202_exc_T10
Reference_point
receiving lidocaine
NCT00904202_exc_T11
Drug
class 1 anti-arrhythmic drugs
NCT00904202_exc_T12
Drug
mexiletine
NCT00904202_exc_T13
Drug
tocainide
NCT00904202_exc_T14
Scope
mexiletine, tocainide